Recent Finacing
Recent Raise
EpiVax is an immune-engineering company that designs and develops vaccines and immunotherapies for infectious diseases, autoimmunity, and cancer, and advances candidates through preclinical and early clinical collaborations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor